Animal models of arrhythmogenic cardiomyopathy

DMM Disease Models and Mechanisms

Volumn 2, Issue 11-12, 2009, Pages 563-570

  McCauley, Mark D ^a   Wehrens, Xander H T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

CELL INTERACTION; CONGESTIVE CARDIOMYOPATHY; CYTOSKELETON; DESMOSOME; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SARCOMERE; SUDDEN DEATH; ZEBRA FISH;

ANIMALS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CALCIUM; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CELL NUCLEUS; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; MICE; MODELS, ANATOMIC; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 70649098394     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.002840     Document Type: Review

References (58)

1. Anderson, E. L. (2006). Arrhythmogenic right ventricular dysplasia. Am. Fam. Physician 73, 1391-1398.
2. Asano, Y., Takashima, S., Asakura, M., Shintani, Y., Liao, Y., Minamino, T., Asanuma, H., Sanada, S., Kim, J., Ogai, A. et al. (2004). Lamr1 functional retroposon causes right ventricular dysplasia in mice. Nat. Genet. 36, 123-130. (Pubitemid 38174369)
3. Awad, M. M., Calkins, H. and Judge, D. P. (2008). Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5, 258-267. (Pubitemid 351593909)
4. Basso, C., Fox, P. R., Meurs, K. M., Towbin, J. A., Spier, A. W., Calabrese, F., Maron, B. J. and Thiene, G. (2004). Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 109, 1180-1185. (Pubitemid 38332624)
5. Baudenbacher, F., Schober, T., Pinto, J. R., Sidorov, V. Y., Hilliard, F., Solaro, R. J., Potter, J. D. and Knollmann, B. C. (2008). Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J. Clin. Invest. 118, 3893-3903.
6. Berul, C. I. (2003). Electrophysiological phenotyping in genetically engineered mice. Physiol. Genomics 13, 207-216. (Pubitemid 37129186)
7. Berul, C. I., McConnell, B. K., Wakimoto, H., Moskowitz, I. P., Maguire, C. T., Semsarian, C., Vargas, M. M., Gehrmann, J., Seidman, C. E. and Seidman, J. G. (2001). Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant Myosin-binding protein C gene. Circulation 104, 2734-2739. (Pubitemid 33108143)
8. Boukens, B. J., Christoffels, V. M., Coronel, R. and Moorman, A. F. (2009). Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias. Circ. Res. 104, 19-31.
9. Boussy, T., Paparella, G., de Asmundis, C., Sarkozy, A., Chierchia, G. B., Brugada, J., Brugada, R. and Brugada, P. (2008). Genetic basis of ventricular arrhythmias. Cardiol. Clin. 26, 335-353, v.
10. Bowles, N. E., Bowles, K. R. and Towbin, J. A. (2000). The "final common pathway" hypothesis and inherited cardiovascular disease: the role of cytoskeletal proteins in dilated cardiomyopathy. Herz 25, 168-175.
11. Brink, A. J. and Lochner, A. (1967). Work performance of the isolated perfused beating heart in the hereditary myocardiopathy of the Syrian hamster. Circ. Res. 21, 391-401.
12. Chen, E. and Ekker, S. C. (2004). Zebrafish as a genomics research model. Curr. Pharm. Biotechnol. 5, 409-413.
13. Dokuparti, M. V., Pamuru, P. R., Thakkar, B., Tanjore, R. R. and Nallari, P. (2005). Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy. J. Hum. Genet. 50, 375-381. (Pubitemid 41367555)
14. Eigenthaler, M., Engelhardt, S., Schinke, B., Kobsar, A., Schmitteckert, E., Gambaryan, S., Engelhardt, C. M., Krenn, V., Eliava, M., Jarchau, T. et al. (2003). Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 285, H2471-H2481. (Pubitemid 37443064)
15. Fiset, C. and Giles, W. R. (2008). Cardiac troponin T mutations promote lifethreatening arrhythmias. J. Clin. Invest. 118, 3845-3847.
16. Frey, N., Franz, W. M., Gloeckner, K., Degenhardt, M., Muller, M., Muller, O., Merz, H. and Katus, H. A. (2000). Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovasc. Res. 47, 254-264. (Pubitemid 30625288)
17. Garcia-Gras, E., Lombardi, R., Giocondo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S. and Marian, A. J. (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J. Clin. Invest. 116, 2012-2021. (Pubitemid 44033325)
18. Grossman, A., Barenboim, E., Azaria, B., Sherer, Y. and Goldstein, L. (2004). Arrhythmogenic right ventricular dysplasia: a possible cause of sudden incapacitation. Aviat. Space Environ. Med. 75, 697-699. (Pubitemid 39006832)
19. Grossmann, K. S., Grund, C., Huelsken, J., Behrend, M., Erdmann, B., Franke, W. W. and Birchmeier, W. (2004). Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J. Cell Biol. 167, 149-160. (Pubitemid 39363422)
20. Haghighi, K., Kolokathis, F., Gramolini, A. O., Waggoner, J. R., Pater, L., Lynch, R. A., Fan, G. C., Tsiapras, D., Parekh, R. R., Dorn, G. W., 2nd et al. (2006). A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. USA 103, 1388-1393.
21. Hatzfeld, M. (2007). Plakophilins: multifunctional proteins or just regulators of desmosomal adhesion? Biochim. Biophys. Acta 1773, 69-77.
22. Hershberger, R. E., Lindenfeld, J., Mestroni, L., Seidman, C. E., Taylor, M. R. and Towbin, J. A. (2009). Genetic evaluation of cardiomyopathy: a heart failure society of america practice guideline. J. Card. Fail. 15, 83-97.
23. Heuser, A., Plovie, E. R., Ellinor, P. T., Grossmann, K. S., Shin, J. T., Wichter, T., Basson, C. T., Lerman, B. B., Sasse-Klaassen, S., Thierfelder, L. et al. (2006). Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 79, 1081-1088. (Pubitemid 44853479)
24. Kannankeril, P. J., Mitchell, B. M., Goonasekera, S. A., Chelu, M. G., Zhang, W., Sood, S., Kearney, D. L., Danila, C. I., De Biasi, M., Wehrens, X. H. et al. (2006). Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc. Natl. Acad. Sci. USA 103, 12179-12184. (Pubitemid 44215831)
25. Keren, A., Syrris, P. and McKenna, W. J. (2008). Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med. 5, 158-168.
26. Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., Paul, M., Athai, T., Hiller, K. H., Baba, H. A. et al. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114, 1799-1806. (Pubitemid 44673354)
27. Kittleson, M. D., Meurs, K. M., Munro, M. J., Kittleson, J. A., Liu, S. K., Pion, P. D. and Towbin, J. A. (1999). Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation 99, 3172-3180.
28. Knollmann, B. C. and Potter, J. D. (2001). Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. Trends Cardiovasc. Med. 11, 206-212.
29. Knollmann, B. C., Kirchhof, P., Sirenko, S. G., Degen, H., Greene, A. E., Schober, T., Mackow, J. C., Fabritz, L., Potter, J. D. and Morad, M. (2003). Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ. Res. 92, 428-436. (Pubitemid 36298203)
30. Kuwahara, K., Saito, Y., Takano, M., Arai, Y., Yasuno, S., Nakagawa, Y., Takahashi, N., Adachi, Y., Takemura, G., Horie, M. et al. (2003). NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22, 6310-6321. (Pubitemid 37522588)
31. MacRae, C. A., Birchmeier, W. and Thierfelder, L. (2006). Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism. J. Clin. Invest. 116, 1825-1828. (Pubitemid 44033303)
32. Marcus, F. and Towbin, J. A. (2006). The mystery of arrhythmogenic right ventricular dysplasia/cardiomyopathy: from observation to mechanistic explanation. Circulation 114, 1794-1795. (Pubitemid 44673352)
33. Marian, A. J. (2008). Genetic determinants of cardiac hypertrophy. Curr. Opin. Cardiol. 23, 199-205.
34. Marian, A. J., Wu, Y., Lim, D. S., McCluggage, M., Youker, K., Yu, Q. T., Brugada, R., DeMayo, F., Quinones, M. and Roberts, R. (1999). A transgenic rabbit model for human hypertrophic cardiomyopathy. J. Clin. Invest. 104, 1683-1692. (Pubitemid 30053185)
35. Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E. and Young, J. B. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 113, 1807-1816. (Pubitemid 43958474)
36. Martin, E. D., Moriarty, M. A., Byrnes, L. and Grealy, M. (2009). Plakoglobin has both structural and signalling roles in zebrafish development. Dev. Biol. 327, 83-96.
37. Meurs, K. M., Lacombe, V. A., Dryburgh, K., Fox, P. R., Reiser, P. R. and Kittleson, M. D. (2006). Differential expression of the cardiac ryanodine receptor in normal and arrhythmogenic right ventricular cardiomyopathy canine hearts. Hum. Genet. 120, 111-118.
38. Moric-Janiszewska, E. and Markiewicz-Loskot, G. (2007). Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace 9, 259-266. (Pubitemid 47079239)
39. Morimoto, S. (2008). Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc. Res. 77, 659-666.
40. Mounkes, L. C., Kozlov, S. V., Rottman, J. N. and Stewart, C. L. (2005). Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum. Mol. Genet. 14, 2167-2180.
41. Nishii, K., Morimoto, S., Minakami, R., Miyano, Y., Hashizume, K., Ohta, M., Zhan, D. Y., Lu, Q. W. and Shibata, Y. (2008). Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo. Dev. Biol. 322, 65-73.
42. Ripplinger, C. M., Li, W., Hadley, J., Chen, J., Rothenberg, F., Lombardi, R., Wickline, S. A., Marian, A. J. and Efimov, I. R. (2007). Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ. Res. 101, 1049-1057. (Pubitemid 350084982)
43. Rohr, S. (2007). Molecular crosstalk between mechanical and electrical junctions at the intercalated disc. Circ. Res. 101, 637-639.
44. Ruan, H., Mitchell, S., Vainoriene, M., Lou, Q., Xie, L. H., Ren, S., Goldhaber, J. I. and Wang, Y. (2007). Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy. Circulation 116, 596-605. (Pubitemid 47356345)
45. Sato, T., Ohkusa, T., Honjo, H., Suzuki, S., Yoshida, M. A., Ishiguro, Y. S., Nakagawa, H., Yamazaki, M., Yano, M., Kodama, I. et al. (2008). Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster. Am. J. Physiol. Heart Circ. Physiol. 294, H1164-H1173.
46. Schmitt, J. P., Debold, E. P., Ahmad, F., Armstrong, A., Frederico, A., Conner, D. A., Mende, U., Lohse, M. J., Warshaw, D., Seidman, C. E. et al. (2006). Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function. Proc. Natl. Acad. Sci. USA 103, 14525-14530. (Pubitemid 44484783)
47. Stokes, D. L. (2007). Desmosomes from a structural perspective. Curr. Opin. Cell Biol. 19, 565-571.
48. Tiso, N., Stephan, D. A., Nava, A., Bagattin, A., Devaney, J. M., Stanchi, F., Larderet, G., Brahmbhatt, B., Brown, K., Bauce, B. et al. (2001). Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189-194. (Pubitemid 32123976)
49. Tsoutsman, T., Chung, J., Doolan, A., Nguyen, L., Williams, I. A., Tu, E., Lam, L., Bailey, C. G., Rasko, J. E., Allen, D. G. et al. (2006). Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J. Mol. Cell Cardiol. 41, 623-632. (Pubitemid 44374544)
50. Tsoutsman, T., Kelly, M., Ng, D. C., Tan, J. E., Tu, E., Lam, L., Bogoyevitch, M. A., Seidman, C. E., Seidman, J. G. and Semsarian, C. (2008). Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation 117, 1820-1831.
51. Wehrens, X. H. (2007). The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm 4, 794-797.
52. Wolf, C. M. and Berul, C. I. (2008). Molecular mechanisms of inherited arrhythmias. Curr. Genomics 9, 160-168.
53. Wolf, C. M., Moskowitz, I. P., Arno, S., Branco, D. M., Semsarian, C., Bernstein, S. A., Peterson, M., Maida, M., Morley, G. E., Fishman, G. et al. (2005). Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc. Natl. Acad. Sci. USA 102, 18123-18128. (Pubitemid 41798512)
54. Wolf, C. M., Wang, L., Alcalai, R., Pizard, A., Burgon, P. G., Ahmad, F., Sherwood, M., Branco, D. M., Wakimoto, H., Fishman, G. I. et al. (2008). Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J. Mol. Cell Cardiol. 44, 293-303.
55. Yang, Z., Bowles, N. E., Scherer, S. E., Taylor, M. D., Kearney, D. L., Ge, S., Nadvoretskiy, V. V., DeFreitas, G., Carabello, B., Brandon, L. I. et al. (2006). Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res. 99, 646-655. (Pubitemid 44401456)
56. Zemljic-Harpf, A. E., Miller, J. C., Henderson, S. A., Wright, A. T., Manso, A. M., Elsherif, L., Dalton, N. D., Thor, A. K., Perkins, G. A., McCulloch, A. D. et al. (2007). Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol. Cell. Biol. 27, 7522-7537. (Pubitemid 350033658)
57. Zheng, M., Cheng, H., Li, X., Zhang, J., Cui, L., Ouyang, K., Han, L., Zhao, T., Gu, Y., Dalton, N. D. et al. (2009). Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum. Mol. Genet. 18, 701-713.
58. Zhou, Q., Chu, P. H., Huang, C., Cheng, C. F., Martone, M. E., Knoll, G., Shelton, G. D., Evans, S. and Chen, J. (2001). Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol. 155, 605-612. (Pubitemid 34289318)